121 related articles for article (PubMed ID: 12743423)
61. Apoptosis dysregulation in human gastric carcinomas: relationship to anti- and pro-apoptotic protein expression.
Nasif WA; El-Emshaty HM; Lotfy M; Zalata K; El-Hak NG
Asian Pac J Cancer Prev; 2007; 8(1):45-50. PubMed ID: 17477770
[TBL] [Abstract][Full Text] [Related]
62. [Correlations of HER-2, PCNA, Bcl-2, and Bax expression to prognosis of breast cancer].
Yang L; Zhu X; Ran L
Ai Zheng; 2007 Jul; 26(7):756-61. PubMed ID: 17626754
[TBL] [Abstract][Full Text] [Related]
63. [Correlation between apoptotic index, bcl-2 protein expression and progression and prognosis in breast carcinoma].
Zhang GJ; Kimijima I; Watanabe T; Kanno M; Sagara H; Furukawa Y; Tsuchiya A; Abe R
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():415-21. PubMed ID: 9589045
[TBL] [Abstract][Full Text] [Related]
64. Bcl2, p53 and clinical outcome in a series of 138 operable breast cancer patients.
Castiglione F; Sarotto I; Fontana V; Destefanis M; Venturino A; Ferro S; Cardaropoli S; Orengo MA; Porcile G
Anticancer Res; 1999; 19(5C):4555-63. PubMed ID: 10650810
[TBL] [Abstract][Full Text] [Related]
65. P53, bcl-2, and Bax expression in renal cell carcinoma.
Vasavada SP; Novick AC; Williams BR
Urology; 1998 Jun; 51(6):1057-61. PubMed ID: 9609655
[TBL] [Abstract][Full Text] [Related]
66. bcl-2 and apoptosis in lymph node positive breast carcinoma.
Berardo MD; Elledge RM; de Moor C; Clark GM; Osborne CK; Allred DC
Cancer; 1998 Apr; 82(7):1296-302. PubMed ID: 9529021
[TBL] [Abstract][Full Text] [Related]
67. Analysis of p53/BAX in primary colorectal carcinoma: low BAX protein expression is a negative prognostic factor in UICC stage III tumors.
Schelwies K; Sturm I; Grabowski P; Scherübl H; Schindler I; Hermann S; Stein H; Buhr HJ; Riecken EO; Zeitz M; Dörken B; Daniel PT
Int J Cancer; 2002 Jun; 99(4):589-96. PubMed ID: 11992551
[TBL] [Abstract][Full Text] [Related]
68. Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance.
Zeng C; Ke Z; Song Y; Yao Y; Hu X; Zhang M; Li H; Yin J
Exp Mol Pathol; 2013 Aug; 95(1):23-31. PubMed ID: 23631820
[TBL] [Abstract][Full Text] [Related]
69. Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer.
Borner MM; Brousset P; Pfanner-Meyer B; Bacchi M; Vonlanthen S; Hotz MA; Altermatt HJ; Schlaifer D; Reed JC; Betticher DC
Br J Cancer; 1999 Feb; 79(5-6):952-8. PubMed ID: 10070896
[TBL] [Abstract][Full Text] [Related]
70. bcl-2 Expression and apoptosis in primary and metastatic breast carcinomas.
Villar E; Redondo M; Rodrigo I; García J; Avila E; Matilla A
Tumour Biol; 2001; 22(3):137-45. PubMed ID: 11275791
[TBL] [Abstract][Full Text] [Related]
71. Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction.
Choudhuri T; Pal S; Agwarwal ML; Das T; Sa G
FEBS Lett; 2002 Feb; 512(1-3):334-40. PubMed ID: 11852106
[TBL] [Abstract][Full Text] [Related]
72. Expression of Bcl-2 in human breast cancer: correlation between hormone receptor status, p53 protein accumulation and DNA strand breaks associated with apoptosis.
Hori M; Nogami T; Itabashi M; Yoshimi F; Ono H; Koizumi S
Pathol Int; 1997 Nov; 47(11):757-62. PubMed ID: 9413034
[TBL] [Abstract][Full Text] [Related]
73. Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma.
Ito T; Fujieda S; Tsuzuki H; Sunaga H; Fan G; Sugimoto C; Fukuda M; Saito H
Cancer Lett; 1999 Jun; 140(1-2):81-91. PubMed ID: 10403545
[TBL] [Abstract][Full Text] [Related]
74. Predictive value of P53, BCL-2, and BAX in advanced head and neck carcinoma.
Casado S; Forteza J; Dominguez S; Abad MT; Perez I; Intxaurbe I; del Campo JM; Lopez R
Am J Clin Oncol; 2002 Dec; 25(6):588-90. PubMed ID: 12478005
[TBL] [Abstract][Full Text] [Related]
75. Bcl-2: bax and bcl-2: Bcl-x ratios by image cytometric quantitation of immunohistochemical expression in ovarian carcinoma: correlation with prognosis.
Lohmann CM; League AA; Clark WS; Lawson D; DeRose PB; Cohen C
Cytometry; 2000 Feb; 42(1):61-6. PubMed ID: 10679744
[TBL] [Abstract][Full Text] [Related]
76. Effects of dehydroepiandrosterone and calorie restriction on the Bcl-2/Bax-mediated apoptotic pathway in p53-deficient mice.
Wang TT; Hursting SD; Perkins SN; Phang JM
Cancer Lett; 1997 Jun; 116(1):61-9. PubMed ID: 9177459
[TBL] [Abstract][Full Text] [Related]
77. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity.
van Slooten HJ; van de Vijver MJ; van de Velde CJ; van Dierendonck JH
Br J Cancer; 1998 Mar; 77(5):789-96. PubMed ID: 9514059
[TBL] [Abstract][Full Text] [Related]
78. Combined p53 and Bcl2 Immunophenotypes in Prognosis of Vietnamese Invasive Breast Carcinoma: A Single Institutional Retrospective Analysis.
Van Nguyen C; Nguyen QT; Vu HTN; Phung HT; Pham KH; Le RD
Technol Cancer Res Treat; 2020; 19():1533033820983081. PubMed ID: 33357134
[TBL] [Abstract][Full Text] [Related]
79. Immunohistochemical localization of Bcl-2 and Bax proteins in in situ and invasive duct breast carcinomas.
Kapucuoglu N; Losi L; Eusebi V
Virchows Arch; 1997 Jan; 430(1):17-22. PubMed ID: 9037310
[TBL] [Abstract][Full Text] [Related]
80. MIB-1 expression in breast carcinomas with medullary features. An immunohistological study including correlations with p53 and bcl-2.
Jensen V; Jensen ML; Kiaer H; Andersen J; Melsen F
Virchows Arch; 1997 Aug; 431(2):125-30. PubMed ID: 9293894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
